Skip to main content
Log in

Choosing between Endocrine Therapy and Chemotherapy – or is there a Role for Combination Therapy?

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Results from many randomized trials of adjuvant breast cancer therapy have been presented in several overviews and at subsequent meetings. This manuscript reviews the current status of both chemo- and endocrine therapy and the prospects for combination therapy, as summarized at the NIH and St Gallen Consensus meetings. In conclusion, treatment selection should be based primarily on endocrine responsiveness; however, a collaborative approach involving the development of new agents and investigation of their optimal integration into therapy programs will ensure progress and improved patient care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Forbes, J.F., Gradishar, W.J. & Ravdin, P.M. Choosing between Endocrine Therapy and Chemotherapy – or is there a Role for Combination Therapy?. Breast Cancer Res Treat 75 (Suppl 1), 37–44 (2002). https://doi.org/10.1023/A:1020365800921

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020365800921

Navigation